NYSE - Nasdaq Real Time Price USD

Envista Holdings Corporation (NVST)

16.64
-1.13
(-6.36%)
At close: May 21 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,503,900
2,510,600
2,566,500
2,569,100
2,508,900
Cost of Revenue
1,151,500
1,137,900
1,126,000
1,094,300
1,082,400
Gross Profit
1,352,400
1,372,700
1,440,500
1,474,800
1,426,500
Operating Expense
1,221,100
1,235,500
1,125,600
1,131,600
1,120,300
Operating Income
131,300
137,200
314,900
343,200
306,200
Net Non Operating Interest Income Expense
-42,800
-46,400
-63,400
-38,400
-54,100
Other Income Expense
-1,179,500
-1,175,500
-306,400
-20,900
2,400
Pretax Income
-1,091,000
-1,084,700
-54,900
283,900
254,500
Tax Provision
33,200
33,900
45,300
45,900
-9,000
Net Income Common Stockholders
-1,124,200
-1,118,600
-100,200
243,100
340,500
Diluted NI Available to Com Stockholders
-1,124,200
-1,118,600
-100,200
243,100
340,500
Basic EPS
-6.54
-6.50
-0.60
1.49
2.11
Diluted EPS
-6.54
-6.50
-0.60
1.37
1.92
Basic Average Shares
172,325
172,200
166,900
162,900
161,200
Diluted Average Shares
172,325
172,200
166,900
177,600
177,600
Total Operating Income as Reported
-1,047,300
-1,038,200
31,500
319,200
306,200
Total Expenses
2,372,600
2,373,400
2,251,600
2,225,900
2,202,700
Net Income from Continuing & Discontinued Operation
-1,124,200
-1,118,600
-100,200
243,100
340,500
Normalized Income
-417,040
-190,034
123,686
258,112
263,500
Interest Expense
42,800
46,400
63,400
38,400
54,100
Net Interest Income
-42,800
-46,400
-63,400
-38,400
-54,100
EBIT
-1,048,200
-1,038,300
8,500
322,300
308,600
EBITDA
-896,800
-883,800
171,100
484,400
460,500
Reconciled Cost of Revenue
1,151,500
1,137,900
1,126,000
1,094,300
1,082,400
Reconciled Depreciation
151,400
154,500
162,600
162,100
151,900
Net Income from Continuing Operation Net Minority Interest
-1,124,200
-1,118,600
-100,200
238,000
263,500
Total Unusual Items Excluding Goodwill
-1,178,600
-1,175,400
-283,400
-24,000
0
Total Unusual Items
-1,178,600
-1,175,400
-283,400
-24,000
0
Normalized EBITDA
281,800
291,600
454,500
508,400
460,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-471,440
-246,834
-59,514
-3,888
0
12/31/2021 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XRAY DENTSPLY SIRONA Inc.
15.83
-5.27%
 
KMTS Kestra Medical Technologies, Ltd.
23.09
-7.34%
 
UTMD Utah Medical Products, Inc.
53.32
-1.66%
 
ICUI ICU Medical, Inc.
130.75
-3.09%
 
ANGO AngioDynamics, Inc.
9.57
+0.63%
 
BLCO Bausch + Lomb Corporation
11.19
-4.77%
 
STVN Stevanato Group S.p.A.
23.99
-1.36%
 
TFX Teleflex Incorporated
121.97
-3.85%
 
AVTR Avantor, Inc.
12.55
-6.83%
 
MMSI Merit Medical Systems, Inc.
96.49
-2.35%